Femara 2.5 mg/1

Femara 2.5 mg is a film-coated tablet containing letrozole, used for specific therapeutic purposes. This medication is commonly prescribed for conditions related to hormone-sensitive treatments.

Femara 2.5 mg is primarily used in the management of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the amount of estrogen in the body, which can help slow or stop the growth of certain types of breast cancer cells. This medication is often used as part of a comprehensive treatment plan.

Common effects of Femara 2.5 mg may include hot flashes, joint pain, fatigue, and hair thinning. Some individuals may also experience nausea, headaches, or dizziness. These effects can vary in intensity and duration among users.

Femara 2.5 mg should be handled with care and stored as directed. It is important to follow the advice of a healthcare provider regarding its use. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies.

Femara 2.5 mg may interact with other medications, including those metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect its efficacy.